Morris D Bell Selected Research

Vocational Rehabilitation

1/2018	Comparison of focused cognitive training and portable "brain-games" on functional outcomes for vocational rehabilitation participants.
8/2016	Addressing defeatist beliefs in work rehabilitation.
1/2016	Neurocognition and occupational functioning in schizophrenia spectrum disorders: The MATRICS Consensus Cognitive Battery (MCCB) and workplace assessments.
3/2013	Beyond cognition: a longitudinal investigation of the role of motivation during a vocational rehabilitation program.
9/2011	Intrinsic motivation as a predictor of work outcome after vocational rehabilitation in schizophrenia.
2/2009	Effects of cognitive behavioral therapy on work outcomes in vocational rehabilitation for participants with schizophrenia spectrum disorders.
10/2005	Cognitive remediation and vocational rehabilitation for schizophrenia.
9/2005	Enhanced cognitive-behavioral therapy for vocational rehabilitation in schizophrenia: Effects on hope and work.
6/2005	Relationship of impaired processing speed and flexibility of abstract thought to improvements in work performance over time in schizophrenia.
3/2002	Insight and work performance in schizophrenia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Morris D Bell Research Topics

Disease

24	Schizophrenia (Dementia Praecox) 01/2022 - 03/2002
9	Psychotic Disorders (Schizoaffective Disorder) 01/2018 - 03/2002
5	Cognitive Dysfunction 01/2021 - 11/2007
3	Substance-Related Disorders (Drug Abuse) 01/2020 - 02/2016
2	Alcoholism (Alcohol Abuse) 01/2021 - 01/2016
2	Mental Disorders (Mental Disorder) 11/2017 - 08/2016
1	Dementia (Dementias) 01/2021
1	Brain Concussion (Cerebral Concussion) 01/2021
1	Alzheimer Disease (Alzheimer's Disease) 10/2016
1	Memory Disorders (Memory Loss) 01/2016

Drug/Important Bio-Agent (IBA)

2	salicylhydroxamic acid (SHAM)IBA 01/2018 - 03/2016
1	Antipsychotic Agents (Antipsychotics)IBA 01/2022
1	Risperidone (Risperdal Consta)FDA LinkGeneric 01/2022
1	Donepezil (Aricept)FDA LinkGeneric 01/2021
1	Cholinesterase Inhibitors (Anticholinesterases)IBA 01/2021
1	acceleratory factor from growth hormone (AcG)IBA 10/2016
1	Opiate AlkaloidsIBA 02/2016
1	Cocaine (Cocaine HCl)IBA 02/2016

Therapy/Procedure

13	Therapeutics 01/2021 - 01/2004
13	Cognitive Training 01/2021 - 01/2004
10	Vocational Rehabilitation 01/2018 - 03/2002
1	Injections 01/2022
1	Ambulatory Care (Outpatient Care) 08/2015